免疫球蛋白A糖化在克罗恩病和性结肠炎之间有所不同
Florent Clerc1, Karli R Reiding1,2,3, Noortje de Haan1
1Center for Proteomics and Metabolomics, Leiden University Medical Center (LUMC), Postbus 9600, Leiden 2300 RC, The Netherlands.
Journal of proteome research
|August 29, 2023
概括
在研究炎症性肠道疾病 (IBD) 中免疫球蛋白A (IgA) 糖化时,这项研究在IBD患者中发现了明显的甘氨酸模式. 这些发现可能会导致克罗恩病的非侵入性生物标志物.
科学领域:
- 葡萄糖化学物质和免疫学
- 胃肠病学和炎症性肠病 (IBD) 研究研究
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),是慢性疾病,患病率越来越高,原因不明,没有确定的治疗方法.
- 目前IBD的诊断方法通常需要侵入性手术,并且需要实验室标记物来分层患者.
- 之前对免疫球蛋白G (IgG) 和血糖化蛋白的糖学研究表明,它们可能是IBD的生物标志物.
研究的目的:
- 与健康对照组相比,研究IBD (CD和UC) 患者血免疫球蛋白A (IgA) 的糖化模式.
- 探索IgA糖化酶作为IBD诊断和患者分层的非侵入性生物标志物的潜力.
- 通过IGA的糖性分析来扩大对IBD病原学的理解.
主要方法:
- 在442名IBD患者 (188名CD,254名UC) 和120名健康对照中分析了免疫球蛋白A1 (IgA1) 和免疫球蛋白A2 (IgA2) 糖化.
- 使用逆相液态染色学电喷离子质谱法 (RPLC-ESI-MS) 测试三性糖.
- 评估了O-和N-糖化中的差异,包括银河糖化,二分化,化和天线性.
主要成果:
- 在IBD患者组 (CD和UC) 和健康对照组之间观察到IgA O和N-糖化模式的显著差异.
- 与银河系化,二分化,化和天线性相关的特定甘氨酸特征在疾病队列中存在差异.
- 基于IgA糖化化特征开发了一个统计模型,以非侵入性预测患者疾病组.
结论:
- 在患有炎症性肠道疾病 (CD和UC) 的患者中,血IgA糖化概况发生变化.
- 作为IBD检测和分类的非侵入性生物标志物,IgA糖化签名显示出前景.
- 这些发现有助于更好地了解IBD机制,并可以通过新的诊断工具来改善患者护理.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
Inflammatory Bowel Disease II: Crohn's Disease
285
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
285
Inflammatory Bowel Disease I: Ulcerative Colitis
213
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
213
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
354
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195


